Literature DB >> 9367818

Expression of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation system.

T Cihlar1, M D Fuller, J M Cherrington.   

Abstract

The catalytic subunit (UL54) and accessory protein (UL44) of human cytomegalovirus (HCMV) DNA polymerase have been cloned and expressed in an in vitro-coupled transcription/translation reticulocyte lysate system. The influence of the 5'-untranslated region (5'-UTR) on the efficiency of expression from the circular plasmids has been investigated. For expression of both UL54 and UL44, a truncated form of the alfalfa mosaic virus (AMV) RNA4 5'-UTR was found to be superior to the full-length AMV 5'-UTR or the original HCMV 5'-UTRs of different lengths. Protein products with Mr approximately 140 and 55 kDa were detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis in the UL54 and UL44 in vitro expression reactions, respectively. The properties of the expressed enzyme were compared with those of native HCMV DNA polymerase purified from HCMV-infected cells. DNA polymerase and 3'-5' exonuclease activities of the expressed UL54/UL44 complex were found to be dependent on salt concentration in the same manner as the activities of the native enzyme. The in vitro-expressed enzyme resembles the purified HCMV DNA polymerase in its affinity for deoxynucleoside triphosphates as well as in its sensitivity to known inhibitors (cidofovir diphosphate, ganciclovir triphosphate, and foscarnet). This straightforward method for protein expression may also be applicable to other enzymes where reproducible generation of fully functional products is desirable. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367818     DOI: 10.1006/prep.1997.0781

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  17 in total

1.  Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44.

Authors:  Arianna Loregian; Brent A Appleton; James M Hogle; Donald M Coen
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit.

Authors:  Arianna Loregian; Brent A Appleton; James M Hogle; Donald M Coen
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54.

Authors:  Frédéric Picard-Jean; Isabelle Bougie; Martin Bisaillon
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

4.  Cloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit.

Authors:  Arianna Loregian; Alessandro Case; Enrico Cancellotti; Carlo Valente; Howard S Marsden; Giorgio Palù
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.

Authors:  Egor P Tchesnokov; Christian Gilbert; Guy Boivin; Matthias Götte
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.

Authors:  Karima Zarrouk; Van Dung Pham; Jocelyne Piret; Rong Shi; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

7.  Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.

Authors:  Jocelyne Piret; Nathalie Goyette; Brian E Eckenroth; Emilien Drouot; Matthias Götte; Guy Boivin
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

8.  Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.

Authors:  T Cihlar; M D Fuller; J M Cherrington
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.

Authors:  Arianna Loregian; Roberto Rigatti; Mary Murphy; Elisabetta Schievano; Giorgio Palu; Howard S Marsden
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Pronounced Inhibition Shift from HIV Reverse Transcriptase to Herpetic DNA Polymerases by Increasing the Flexibility of α-Carboxy Nucleoside Phosphonates.

Authors:  Jubi John; Youngju Kim; Nicholas Bennett; Kalyan Das; Sandra Liekens; Lieve Naesens; Eddy Arnold; Anita R Maguire; Matthias Götte; Wim Dehaen; Jan Balzarini
Journal:  J Med Chem       Date:  2015-10-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.